PMID- 24820142
OWN - NLM
STAT- MEDLINE
DCOM- 20150423
LR  - 20211021
IS  - 1434-9949 (Electronic)
IS  - 0770-3198 (Linking)
VI  - 33
IP  - 9
DP  - 2014 Sep
TI  - Remission criteria and activity indices in psoriatic arthritis.
PG  - 1323-30
LID - 10.1007/s10067-014-2626-y [doi]
AB  - Remission criteria and activity indices used in rheumatoid arthritis (RA) are 
      often applied in psoriatic arthritis (PsA). Some new indices have been 
      specifically developed for PsA. Our objective was to evaluate the performance of 
      different remission criteria and activity indices in PsA. This is a 
      cross-sectional study that includes consecutive patients with PsA. Information 
      necessary to complete the following indices was captured: Composite Psoriatic 
      Disease Activity Index (CPDAI), Psoriatic Arthritis Screening and Evaluation 
      (PASE), Disease Activity Index for Psoriatic Arthritis (DAPSA), Disease Activity 
      Score in 28 Joints (DAS28), Simplified Disease Activity Index (SDAI), Clinical 
      Disease Activity Index (CDAI), and American College of Rheumatology and European 
      League Against Rheumatism (ACR/EULAR) Boolean RA remission criteria. Patients 
      were classified according to activity categories (remission, low, medium, or high 
      disease activity). Correlation between indices was established. Fifty-five 
      patients were included. Mean age was 53 years (SD = 12), and 35 (63.6 %) were 
      males. Mean PsA disease duration was 5.9 years (SD = 8.5), and mean psoriasis 
      duration was 15.9 (SD = 12.6). We found important differences in the percentage 
      of patients classified as in remission by applying different remission criteria: 
      DAS28 = 33 % (95 % confidence interval (CI) 20-45) vs ACR/EULAR = 4 % (95 % CI 
      1-17). Particularly, DAS28 and minimal disease activity seemed to be less 
      stringent in PsA than the other indices. Of the specific PsA indices evaluated, 
      CPDAI showed the poorest correlation with all the other activity measurements, 
      although differences were not statistically significant in most cases. Disease 
      activity in PsA is measured by many different indices. In spite they all showed 
      good correlations between them, they classified different patients in different 
      disease status.
FAU - Acosta Felquer, M L
AU  - Acosta Felquer ML
AD  - Rheumatology Section, Medical Services, Hospital Italiano de Buenos Aires, 
      Instituto Universitario Escuela de Medicina Hospital Italiano de Buenos Aires and 
      Fundacion Dr. Pedro M Catoggio para el Progreso de la Reumatologia, Peron 4190 
      (1181), CABA, Buenos Aires, Argentina.
FAU - Ferreyra Garrott, L
AU  - Ferreyra Garrott L
FAU - Marin, J
AU  - Marin J
FAU - Catay, E
AU  - Catay E
FAU - Scolnik, M
AU  - Scolnik M
FAU - Scaglioni, V
AU  - Scaglioni V
FAU - Ruta, S
AU  - Ruta S
FAU - Rosa, J
AU  - Rosa J
FAU - Soriano, E R
AU  - Soriano ER
LA  - eng
PT  - Journal Article
DEP - 20140513
PL  - Germany
TA  - Clin Rheumatol
JT  - Clinical rheumatology
JID - 8211469
RN  - 0 (Antirheumatic Agents)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antirheumatic Agents/*therapeutic use
MH  - Arthritis, Psoriatic/*diagnosis/*drug therapy
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Remission Induction
MH  - Severity of Illness Index
EDAT- 2014/05/14 06:00
MHDA- 2015/04/24 06:00
CRDT- 2014/05/14 06:00
PHST- 2014/01/25 00:00 [received]
PHST- 2014/04/10 00:00 [accepted]
PHST- 2014/04/08 00:00 [revised]
PHST- 2014/05/14 06:00 [entrez]
PHST- 2014/05/14 06:00 [pubmed]
PHST- 2015/04/24 06:00 [medline]
AID - 10.1007/s10067-014-2626-y [doi]
PST - ppublish
SO  - Clin Rheumatol. 2014 Sep;33(9):1323-30. doi: 10.1007/s10067-014-2626-y. Epub 2014 
      May 13.